Siemens
In Brief This Week: Siemens Healthineers, Illumina, Thermo Fisher Scientific, and More
News items for the in vitro diagnostic industry for the week of Sept. 27, 2021.
IVD company executives noted that the acceptance and acceleration of decentralized care models have increased, enabling more effective testing for many conditions.
Siemens Healthineers, A1 Life Sciences Ink Agreement to Provide SARS-CoV-2 Variant Assays
Laboratories will be able to select specific assays to produce a testing scheme based on mutations prevalent in a region, Siemens Healthineers said.
Siemens Healthineers Obtains EU IVD Certifications to Enable Continued Sale of Current Tests
The firm said it is steadily implementing new EU regulatory requirements and preparing to have more than 4,000 products certified by May 2022.
FDA Grants De Novo Authorization for Siemens Healthineers' Enhanced Liver Fibrosis Blood Test
The ELF Test provides prognostic information to assess the likelihood of a NASH patient progressing to cirrhosis and liver-related clinical events.
Jun 30, 2021
Feb 25, 2021